BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15870878)

  • 21. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
    Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
    Guo Y; Fu P; Zhu H; Reed E; Remick SC; Petros W; Mueller MD; Yu JJ
    Oncol Rep; 2012 Jan; 27(1):286-92. PubMed ID: 21971700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.
    Zhang GL; Xu KL
    Int J Gynecol Cancer; 2002; 12(2):198-201. PubMed ID: 11975680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
    Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer.
    Kawakami M; Staub J; Cliby W; Hartmann L; Smith DI; Shridhar V
    Int J Oncol; 1999 Oct; 15(4):715-20. PubMed ID: 10493953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
    Liu J; Jin S; Wang R
    Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors.
    Edelson MI; Lau CC; Colitti CV; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(2):197-202. PubMed ID: 9464537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
    Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C
    Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
    Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D; Matte I; Garde-Granger P; Laplante C; Carignan A; Rancourt C; Piché A
    BMC Cancer; 2015 Jul; 15():492. PubMed ID: 26122176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.